Network News

Ruperto Carola is ranked among the world’s “Top 50” and one of the top three universities in Germany Heidelberg University is one of the top three universities in Germany, ranking third in the 2025/2026 Times Higher Education World University Rankings, which have just been published. In 49th position internationally, it is among the world’s “Top […]

AbbVie is launching a US and Europe based golden ticket. The award consists of one golden ticket, which provides one year of fully paid individual bench, a desk and membership at one of BioLabs’ operating locations in the US, France or Germany. The award is intended for early-stage biotech companies developing therapeutics (not devices) in […]

Double success for Heidelberg life sciences: Two of the three prestigious Life Sciences Bridge Awards presented this year go to Heidelberg University’s Medical Faculty. The Aventis Foundation honors infectious disease specialist Dr. Frauke Mücksch and neurologist Dr. Varun Venkataramani for their groundbreaking research. While Mücksch is searching for new ways to one day cure HIV […]

Got a startup idea? Curious about entrepreneurship? Then the GeneNovate program is the perfect place to start! Objective GeneNovate is the first nationwide entrepreneurship program in Germany, designed to empower innovators and entrepreneurs in the field of Gene and Cell Therapies (GCT), Biotech and Medicine. The program targets early-career scientists and physicians, such as advanced […]

Chicago, IL – October 8th, 2025 – VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable development of genetic medicines. The manuscript detailing this breakthrough is now published on BioRxiv. Plasmids have long been a key material […]

October 7, 2025 Celonic Group one of the leading “pureplay” Biologics CDMO, and The Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, today announced a strategic partnership to offer a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing solution. The alliance combines Celonic’s advanced biologics capabilities with CARBOGEN […]

Chicago, IL – SEPTEMBER 30th, 2025 – VectorBuilder, a global leader in the gene delivery space, has won two prestigious awards at the Asia-Pacific Cell and Gene Therapy Excellence Awards 2025 (APCGTEA) and the Asia-Pacific Biologics CDMO Excellence Awards 2025 (APBCEA), hosted by IMAPAC. ● Best Cell & Gene Therapy Supplier Award – AAV Vector Manufacturing ● Best Gene […]

Ladenburg, Germany, 25 September 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced the initiation of Cohort 9 in its ongoing Phase I/IIa dose escalation trial of HDP-101, the Company’s lead ATAC candidate for the treatment of relapsed or refractory multiple myeloma. The Safety Review Committee […]

Ladenburg, Germany, 25 September 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today resolved with the approval of the Supervisory Board to implement extensive cost-saving measures and consequently, to focus all development activities exclusively on lead ADC candidate HDP-101 to extend the Company’s cash reach. This […]